Anika Kremer
Overview
Explore the profile of Anika Kremer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Goubergen J, Perina M, Handle F, Morales E, Kremer A, Schmidt O, et al.
Mol Oncol
. 2024 Sep;
19(2):496-518.
PMID: 39258426
In advanced prostate cancer (PC), in particular after acquisition of resistance to androgen receptor (AR) signaling inhibitors (ARSI), upregulation of AR splice variants compromises endocrine therapy efficiency. Androgen receptor splice...
2.
Stein J, Krappe E, Kremer A, Cronauer M, Essler M, Cox A, et al.
J Cancer Res Clin Oncol
. 2024 Feb;
150(2):76.
PMID: 38310601
Purpose: Investigation of Microtubuli-associated Protein 2 (MAP2) expression and its clinical relevance in prostate cancer. Material And Methods: MAP2 expression was immunohistochemically analysed on radical prostatectomy specimens using whole block...
3.
Wambach M, Montani M, Runz J, Stephan C, Jung K, Moch H, et al.
APMIS
. 2024 Jan;
132(4):256-266.
PMID: 38288749
Human anterior gradient-2 (AGR2) has been implicated in carcinogenesis of various solid tumours, but the expression data in prostate cancer are contradictory regarding its prognostic value. The objective of this...
4.
Tolkach Y, Kremer A, Lotz G, Schmid M, Mayr T, Forster S, et al.
Cancers (Basel)
. 2022 Sep;
14(18).
PMID: 36139600
Background: Canonical androgen receptor (AR) signaling regulates a network of DNA repair genes in prostate cancer (PCA). Experimental and clinical evidence indicates that androgen deprivation not only suppresses DNA repair...
5.
Tolkach Y, Goltz D, Kremer A, Ahmadzadehfar H, Bergheim D, Essler M, et al.
Oncotarget
. 2019 Jul;
10(41):4149-4160.
PMID: 31289613
Aim: The prostate-specific membrane antigen (PSMA) is currently being established as a potent diagnostic marker in many tumor types. So far, its evidence in hepatocellular carcinoma (HCC) is sparse. The...
6.
Kremer A, Kremer T, Kristiansen G, Tolkach Y
BMC Urol
. 2019 Jun;
19(1):46.
PMID: 31170942
Background: The identification of appropriate biomarkers is essential to support important clinical decisions in patients with prostate cancer. The aim of our study was a systematic bioinformatical analysis of the...
7.
Tolkach Y, Ellinger J, Kremer A, Esser L, Muller S, Stephan C, et al.
Br J Cancer
. 2019 Feb;
120(6):633-639.
PMID: 30783205
Background: The APLNR (apelin receptor) has been shown to be an essential gene for cancer immunotherapy, with deficiency in APLNR leading to immunotherapy failure. The aim of this study is...
8.
Kremer A, Li S
Microbiology (Reading)
. 2009 Sep;
156(Pt 1):278-286.
PMID: 19762440
A putative prenyltransferase gene sirD has been identified in the gene cluster encoding the biosynthesis of the phytotoxin sirodesmin PL in Leptosphaeria maculans. The gene product was found to comprise...
9.
Stec E, Steffan N, Kremer A, Zou H, Zheng X, Li S
Chembiochem
. 2008 Aug;
9(13):2055-8.
PMID: 18677738
No abstract available.
10.
Kremer A, Li S
Chem Biol
. 2008 Jul;
15(7):729-38.
PMID: 18635009
Recently, five indole prenyltransferases from Aspergillus fumigatus have been proven biochemically to be responsible for prenylations of diverse substrates. In this study, we show peptidase activities of 7-DMATS, FgaPT1, CdpNPT,...